GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Price-to-Tangible-Book

Biosergen AB (OSTO:BIOSGN) Price-to-Tangible-Book : 7.85 (As of Dec. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Price-to-Tangible-Book?

As of today (2024-12-12), Biosergen AB's share price is kr0.644. Biosergen AB's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was kr0.08. Hence, Biosergen AB's Price to Tangible Book Ratio of today is 7.85.

The historical rank and industry rank for Biosergen AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:BIOSGN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.77   Med: 7.41   Max: 20.81
Current: 8.05

During the past 4 years, Biosergen AB's highest Price to Tangible Book Ratio was 20.81. The lowest was 1.77. And the median was 7.41.

OSTO:BIOSGN's Price-to-Tangible-Book is ranked worse than
81.21% of 1203 companies
in the Biotechnology industry
Industry Median: 2.93 vs OSTO:BIOSGN: 8.05

A closely related ratio is called PB Ratio. As of today, Biosergen AB's share price is kr0.644. Biosergen AB's Book Value per Sharefor the quarter that ended in Sep. 2024 was kr0.08. Hence, Biosergen AB's P/B Ratio of today is 7.85.


Biosergen AB Price-to-Tangible-Book Historical Data

The historical data trend for Biosergen AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosergen AB Price-to-Tangible-Book Chart

Biosergen AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- 7.53 1.95 20.81

Biosergen AB Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.36 20.81 1.77 2.76 7.41

Competitive Comparison of Biosergen AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Biosergen AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosergen AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosergen AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Biosergen AB's Price-to-Tangible-Book falls into.



Biosergen AB Price-to-Tangible-Book Calculation

Biosergen AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=0.644/0.082
=7.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Biosergen AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Biosergen AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosergen AB Business Description

Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Solna, SWE, 17165
Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines